Novo Nordisk A/S

NCT07415954

Phase 2Recruiting270 people17 Feb 2026clinicaltrials.gov

NCT07400107

Phase 3Not yet recruiting1,000 people10 Feb 2026clinicaltrials.gov

NCT07271251

Phase 3Completed267 people9 Dec 2025clinicaltrials.gov

NCT07253285

Phase 3Recruiting460 people28 Nov 2025clinicaltrials.gov

NCT07225816

Phase 1Recruiting71 people10 Nov 2025clinicaltrials.gov

NCT07087795

Phase 1Active, not recruiting96 people28 Jul 2025clinicaltrials.gov

NCT07076199

Phase 3Active, not recruiting877 people22 Jul 2025clinicaltrials.gov

NCT07010432

Phase 1Recruiting144 people8 Jun 2025clinicaltrials.gov

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Phase 2Recruiting200 people19 May 2025clinicaltrials.gov

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

CollaboratorPhase 4Not yet recruiting1,020 people18 May 2025clinicaltrials.gov

NCT06813924

Phase 1Completed37 people7 Feb 2025clinicaltrials.gov

NCT06789900

CollaboratorPhase 2Active, not recruiting136 people23 Jan 2025clinicaltrials.gov

NCT06780449

Phase 3Active, not recruiting400 people17 Jan 2025clinicaltrials.gov

NCT06717698

Phase 2Recruiting465 people5 Dec 2024clinicaltrials.gov

NCT06571383

Phase 4Active, not recruiting500 people26 Aug 2024clinicaltrials.gov

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Phase 2Completed448 people7 Aug 2024clinicaltrials.gov

NCT06534411

Phase 3Completed1,023 people2 Aug 2024clinicaltrials.gov

NCT06409130

Phase 2Completed270 people10 May 2024clinicaltrials.gov

NCT06403761

Phase 1Completed158 people8 May 2024clinicaltrials.gov

NCT06388187

Phase 3Completed300 people29 Apr 2024clinicaltrials.gov